Interactions between digitoxin, flecainide and prajmalium bitartrate?
Jähnchen, E.
Deutsche Medizinische Wochenschrift 116(26): 1035-1036
1991
ISSN/ISBN: 0012-0472 PMID: 1905622 Document Number: 373026
Document emailed within 1 workday
Related Documents
Molinis, G.; Valente, M.; Tuniz, D.; Maisano, G. 1981: Prajmalium bitartrate in the long-term treatment of hyperkinetic ventricular arrhythmias. Preliminary study Bollettino della Societa Italiana di Cardiologia 26(7): 657-662Nitsch, J.; Köhler, U.; Neyses, L.; Lüderitz, B. 1988: Concentrations of amiodarone and flecainide in plasma and saliva--indications for the active transport of flecainide Zeitschrift für Kardiologie 77(2): 99-102
Löllgen, H.; Kasperski, J.; Krekeler, H. 1978: Fatal intoxication with ajmaline-bitartrate Die Medizinische Welt 29(23): 979-983
Lindberg, S.; Hybbinette, J.C.; Mercke, U. 1985: Effects of nicotine bitartrate on mucociliary activity European Journal of Respiratory Diseases 66(1): 40-46
Brounley, D.W. 1971: A comparison of pilocarpine hydrochloride and epinephrine bitartrate Annals of Ophthalmology 3(9): 970
Lambrecht, G. 1983: Current pharmacology: flecainide Medizinische Monatsschrift für Pharmazeuten 6(5): 129-130
Frabetti, F.; Dattola, L.; Bellodi, G.; Padovani, F. 1988: Severe proarrhythmic effects of flecainide La Clinica Terapeutica 127(1): 43-47
Bramann, H.U.; Bender, F.; Jachmann, H.; Grosse-Heitmeyer, W. 1984: Long-term therapy with flecainide Zeitschrift für Kardiologie 73(11): 724-731
Leclercq, J.F. 1985: New antiarrhythmia agents: propafenone and flecainide Presse Medicale 14(12): 685-689
Paperini, L.; Davini, A.; Lattanzi, F.; Topi, A.; Reisenhofer, B.; Squarcini, G.; Paci, A.; Topi, P.L. 1995: Propafenone and flecainide in the therapy of ventricular arrhythmias Minerva Cardioangiologica 43(10): 449-457
McQuinn, R.L.; Quarfoth, G.J.; Johnson, J.D.; Banitt, E.H.; Pathre, S.V.; Chang, S.F.; Ober, R.E.; Conard, G.J. 1984: Biotransformation and elimination of 14C-flecainide acetate in humans Drug Metabolism and Disposition: the Biological Fate of Chemicals 12(4): 414-420
Seipel, L.; Abendroth, R.R.; Breithardt, G. 1981: Electrophysiological effects of the new antiarrhythmic drug flecainide (R 818) in man Zeitschrift für Kardiologie 70(7): 524-529
Mletzko, R.; Jung, W.; Manz, M.; Kamradt, T.; Vogel, F.; Lüderitz, B. 1989: Arrhythmogenic effect of flecainide--treatment with I.v. magnesium Zeitschrift für Kardiologie 78(9): 602-606
Baczyński, R. 1977: Pharmakokinetics of digoxin and digitoxin Polski Tygodnik Lekarski 32(20): 773-776
Castle, M.C.; Lage, G.L. 1973: Metabolism and distribution of digitoxin in the rat Archives Internationales de Pharmacodynamie et de Therapie 203(2): 323-334
Gundersen, T.; Rønnevik, P.K. 1981: Attempted suicide with digitoxin Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 101(5): 327-328
Keller, F.; Kreutz, G. 1980: No quinidine interaction with digitoxin Deutsche Medizinische Wochenschrift 105(19): 701-702
Vöhringer, H.F.; Leopold, G.; Rietbrock, N. 1978: Biological availabilty of digitoxin Fortschritte der Medizin 96(2): 71
De Micheli, A.; Medrano, G.A.; Casanova, J.M. 1995: The action of intravenous flecainide in experimental ventricular arrhythmias Archivos del Instituto de Cardiologia de Mexico 65(5): 403-412
Senior, S.; Baessler, C.; Monzo, M. 1988: Flecainide acetate: critical care administration guidelines Heart and Lung: the Journal of Critical Care 17(1): 76-80